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Infections caused by coagulase-negative staphylococci 
(CNS) are commonly associated with implanted 
devices such as intravascular catheters, prosthetic heart 
valves and shunts [ 1,2]. Although several typing systems 
have helped to elucidate their epidemiology and mode 
of transmission, and to define outbreaks of nosocomial 
infections [3-6], little is known about the hospital 
epidemiology of CNS, including both methicdlin- 
resistant and methicillin-sensitive strains (MRCNS 
and MSCNS respectively). This is hrther complicated 
by the ubiquitous nature of CNS as human skin 
flora. CNS may also serve as a reservoir for antibiotic 
resistance genes that can be potentially transferred to 
other Gram-positive organisms, including Stuphylococcus 
aureus [7]. In order to better understand the epidemio- 
logy of antimicrobial resistance in CNS within the 
Heinrich-Heine University Hospital, Diisseldorf, routine 
susceptibility data for isolates derived from different 
body sites in patients from intensive care units (ICUs), 
regular wards and the bone marrow transplantation unit 
were reviewed. 
The Heinrich-Heine University Hospital Dussel- 
dorf is a 1500-bed hospital comprising regular care 
units and five units devoted to intensive medical care, 
namely the surgical ICU, pediatric ICU, neurologic 
ICU, internal medicine ICU and bone marrow trans- 
plant (BMT) unit. Between 1991 and 1996, all clinically 
significant CNS isolates &om blood cultures, catheter 
tips, liquors and aspirates, and all isolates &om immuno- 
compromised patients and other patients where CNS 
were suspected to be involved in a bacteremic episode, 
were referred for confirmation of identity and suscepti- 
bility testing. 
Isolates were identified as CNS by demonstra- 
ting a positive catalase test, a negative coagulase test 
(Bacto Coagulase Plasma EDTA-Test, Difco, Augsburg, 
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Germany), a negative nuclease test (DNase agar, 
Oxoid, Wesel, Germany), and showing no anaerobic 
mannitol metabolism. ATCC reference strains 25923, 
29213 and 33591 were used as controls. 
Susceptibility to antibiotics was detected using 
agar diffusion tests and breakpoints according to the 
Deutsches Institut fur Normung (DIN) guidelines [8] 
and were reported as susceptible (S), intermediate (I) or 
resistant (R). Organisms were susceptibility tested to 
the following antibiotics, with breakpoint criteria 
defined as follows listed by drug, disk load (shown in 
parentheses as pg) and S, I and R category breakpoints 
shown in mm: oxacillin (5) 16, -, 15; penicillin G (6) 
29, -, 28; gentamicin (10) 21, 15-20, 14; netilmicin 
(10) 22, 17-21, 16: tetracycline (30) 22, 17-21, 16; 
ciprofloxacin (5) 23, 19-22, 18; ofloxacin (5) 22, 
18-21, 17; co-trimoxazole (1.25/23.75) 16, 11-15, 10; 
erythromycin (1 5) 2 1, 17-20, 16; clindamycin (1 0) 24, 
19-23, 18; teicoplanin (30) 14, -, 10; chloramphenicol 
(30) 21, -, 20; vancomycin (30) 14, -, 10; fosfomycin 
(100) 20, 19-14, 13; fusidic acid (10) 20, -, 19; and 
rifampicin (30) 25, -, 24. A single dash indicates no 
intermediate class designated. 
Between 1991 and 1996, a total of 6323 CNS 
considered to be clinically significant were isolated 
from different sample materials. Of these, 3 541 (56%) 
isolates were methicillin susceptible and 2 782 (44%) 
isolates were methicillin resistant. Of isolates from 
regular wards, 1126 of 3631 (31%) were MRCNS, 
while 1 138 of 1581 (72%) of isolates from ICUs and 
5 18 of 1 11 1 (52%) of isolates from the BMT unit were 
MRCNS (p<0.05 using the chi-squared test). Despite 
the units being heterogeneous with respect to patient 
populations, prescribed antibiotic regimens and duration 
of hospital stay (data not shown), the proportion of 
MRCNS isolates from each of the four ICUs remained 
between 68% and 72% (Table 1). Between 70% and 
87% of CNS from either blood cultures or from 
Table 1 Numbers of CNS from body sites in different ICUs 
catheters derived from each of the ICUs were methcillin 
resistant, while the rate of methicillin resistance among 
CNS from other sources (e.g. liquor, aspirates, wound 
swabs) varied from 55% to 65% (Table 1). The signifi- 
cantly higher prevalence of methicillin resistance in 
isolates derived from blood or catheter tips (p<0.05), 
as compared to isolates derived from other sites of 
infection, probably reflects exposure to higher concen- 
trations of antibiotics. 
It is known that methicillin resistance in staphylo- 
cocci also predicts resistance to multiple classes of 
antibiotics besides p-lactams [7]. In accordance with 
this observation, the MRCNS isolates showed signi- 
ficantly increased resistance to other antimicrobials, 
especially to quinolones and aminoglycosides (Table 2). 
Methicillin resistance can be used as a fairly reliable 
marker for resistance to a range of different drugs. 
Therefore, it is clearly prudent to assume that MRCNS 
are multiresistant and to carefully tailor therapeutic 
regimens according to susceptibility test results. 
A significant increase in the in vitro resistance to 
all drugs tested, with the exception of glycopeptides, 
was observed for isolates derived from ICUs as com- 
pared to those derived from regular wards. This was 
especially so for the prevalence of resistance to cipro- 
floxacin and ofloxacin, which increased in MSCNS 
from 9% to 34% between the two sample groups. 
Similarly, MRCNS isolates derived from ICUs were 
more resistant to each of the antibiotics tested, again 
with the exception of glycopeptides, than MRCNS 
isolated from the rest of the hospital, with particularly 
noticeable increases in resistance to ciprofloxacin and 
ofloxacin, from 42% and 41% to 73% and 76%, respec- 
tively (pC0.05). Similarly, resistance to netilmicin 
increased from 10% to 28% (pc0.05). Similar patterns 
of increasing resistance in the susceptibility profiles of 
CNS have been reported previously [2,7,9-121. The 
results of the EPIC Study focusing specifically on 
Surgical 
ICU 
Pedatric 
ICU 
Internal Neurosurgical 
ICU ICU 
BC" 
CT 
0 s '  
67 (18%) 
(78% MR) 
197 (53%) 
(87% MR) 
107 (29%) 
(65% MR) 
60 (20%) 
(70% MR) 
151 (50%) 
(78% MR) 
91 (30%) 
(55% MR) 
50 (16%) 
(70% MR) 
33 (15%) 
(80% MR) 
170 (54%) 134 (61%) 
(74% MR) (76% MR) 
95 (30%) 
(57% MR) 
53 (23%) 
(57% MR) 
Total 371 302 315 220 
(72% MR) (70% MR) (68% MR) (72% MR) 
"BC, CNS from blood cultures; bCT, CNS from catheter tips; 'OS, CNS from other sources (e.g. wound swabs, aspirates etc.); 
MR. methicillin resistant. 
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Table 2 Resistance patterns of MSCNS and MRCNS from all hospital units. S, I and R values were calculated using DIN 
interpretative criteria [8]. Data points are shown as percentage values 
MSCNS (n=3541) MRCNS (n=2782) 
Antibiotics S I R S I R 
Penicillin 28 - 72 0 - 100 (p<0.05)" 
Gentamicin 79 4 17 16 10 74 (p<0.05) 
Netilmicin 92 4 4 66 18 16 (p<0.05) 
Tetracycline 77 5 18 69 4 27 NSb 
Ciprofloxacin 80 4 16 40 5 55 (p<0.05) 
Ofloxacin 81 3 16 41 5 54 (p<0.05) 
Co-tr imoxazole 69 0 31 21 0 79 (p<0.05) 
Erythromycin 61 0 39 20 0 80 (pc0.05) 
Clindamycin 79 0 21 33 0 67 (p<0.05) 
Teicoplanin 100 0 0 100 0 0 NS 
Vancomycin 100 0 0 100 0 0 NS 
Additional tested antibiotics 
Chloramphenicol Not tested 86 0 14 
Fusidic acid Not tested 60 0 40 
Rifampicin Not tested 71 0 29 
Fosfomycin Not tested 55 0 45 
"P-values were calculated using the chi-squared test. bNS, non-significant. 
European ICU isolates showed that 70% of the CNS 
isolated were multiresistant MRCNS [2]. 
An analysis of methicillin resistance (and, by 
inference, multiple-drug resistance) in CNS isolates 
h m  regular care units, from ICUs and from the BMT 
unit showed a significant yearly increase between 1991 
and 1996. Whereas in 1991 only 27% of CNS from 
regular care units were resistant to methicillin, by 1996 
this had increased to 36% (pCO.05). During this same 
period, methicillin resistance in CNS isolates from the 
ICUs and the BMT unit increased from 62% and 
44% in 1991 to 78% and 58%, respectively, in 1996 
(pCO.05). In a similar study during a 6-year period, 
Durand-Gasselin et al showed an increase in MRCNS 
from 33% to 56% on a hematology unit [l 11. 
It is important to note that methicdhn resistance is 
much more frequently encountered in CNS than in 
isolates of S. aureus [13]. This is apparent in the 
Heinrich-Heine University Hospital, where about 6% 
of S. aureus isolates are methicillin resistant [14]. As 
antibiotics used to treat infections with both organisms 
are often the same, the selective pressure of antibiotic 
use alone cannot explain the selection or frequency of 
MRCNS, especially in ICUs. As CNS are ubiquitous 
skin organisms and can spread easily on skin particles 
or by air, hygiene measures implemented primarily to 
prevent S. aureus cross-infections may not be sufficient 
to control transmission of MRCNS. 
It is clear that the prevalences of MRCNS in each 
of the four ICUs were similar, even though aspects of 
medical care and patient demography differed between 
them. In addition, a uniform increase of methicillin 
and associated multiresistance was noted in all units 
during the study period. This may provide circum- 
stantial evidence to indicate continuous transmission of 
MRCNS between staff and patients in the ICUs. 
Data from the BMT unit provided some evidence 
to support this hypothesis that MRCNS strains 
are continuously transmitted throughout the hospital 
between both staff and patients. The BMT unit has 
long-term patients in residence, a high consumption of 
broad- and narrow-spectrum antibiotics, and a rigorous 
standard of infection control and hygiene. Compared 
to the four ICUs, the BMT unit had a 20-25% lower 
incidence of methcillin resistance. Thls suggests that 
if the cycle of transmission is broken by extreme 
conditions of hygiene (such as those enforced within 
the BMT unit), it is possible to limit the extent of 
resistance. In contrast to MRSA [15], the transmission 
ofMRCNS is notoriously hard to demonstrate because 
of the ubiquitous nature of CNS. 
In conclusion, it is clear that the prevalence of 
methicillin resistance and associated multiresistance in 
CNS has increased significantly during the 6-year study 
period. Differences can be seen between the suscepti- 
bility profiles of CNS from ICUs and regular hospital 
units. The reduced prevalence of MRCNS isolates 
from the BMT unit, compared to the ICUs, may 
provide circumstantial evidence that hygiene plays a key 
role in controlling the circulation of these organisms 
within the hospital environment. 
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Burkholderia cepacia has emerged as an important cause 
of pulmonary sepsis in individuals with cystic fibrosis 
(CF). Colonization of the airways with this bacterium, 
which often occurs in the second decade of life, is 
associated with three outcomes: chronic asymptomatic 
carriage, progressive deterioration over a prolonged 
period, or a rapidly fatal necrotizing pneumonia [l]. 
Putative virulence factors of B. cepacia remain 
ill-defined, although there is increasing evidence to 
suggest that the bacterium can invade respiratory 
epithelial cells and may thus behave as a facultative 
intracellular pathogen [2,3]. Another member of the 
genus Burkkolderia, B. pseudomallei-the causative agent 
of melioidosis-can also act in this manner [4]. 
Following observations that insulin-dependent 
(type I) diabetes is a risk factor for the development 
of the septicemic form of melioidosis, Woods et a1 
investigated the possibility that insulin may influence 
the growth of B. pseudomallei [5] and reported that 
recombinant human insulin inhibited the growth of 
this bacterium. 
As diabetes is a well-recognized complication of 
CF, we have examined whether a similar interaction 
between B. cepacia and insulin might also occur. More- 
over, our findings, in conjunction with doubts raised 
over the conclusions ofWoods et a1 [6],  suggest that the 
hypothesis that recombinant human insulin affects the 
growth of B. pseudomallei merits re-examination. 
Two strains of B. cepacia were examined. C1359, 
isolated &om a CF patient, was a generous gift from Dr 
J. R. W Govan of the University of Edinburgh Medical 
School, and NCTC 10661, an environmental isolate, 
